| Name | Title | Contact Details |
|---|---|---|
Justin Wiser |
VP CFO Hospital Enterprise | Profile |
Michelle Suddeth |
Director of Marketing | Profile |
Carol Jennings |
Vice President Talent Strategy | Profile |
Michael Bowling |
Vice President of Human Resources | Profile |
THC.com is the safe place to connect about all things cannabis. THC.com is social media that supports YOU. Get paid on product endoresments!
About Arrhythmia Research Technology, Inc. The Company through itswholly-owned subsidiary, Micron Products, Inc. manufacturescomponents, devices and equipment primarily for the medical anddefense industries. Micron is engaged in the production and sale ofsilver/silver chloride coated and conductive resin sensors used ascomponent parts in the manufacture of integrated disposableelectrophysiological sensors. These disposable medical devices areused worldwide in the monitoring of electrical signals in variousmedical applications. The Company has expanded into customthermoplastic injection molded products with a full array of design,engineering and production services and management. The addition ofan orthopedic implant machining operation produces quick-turn, highvolume and patient-specific, finished orthopedic implants. TheCompany also has developed and distributes a customizable proprietarysignal-averaging electrocardiography (SAECG) software used in thedetection of certain heart arrhythmias and that is reconfigurable fora variety of hardware platforms.
reportassistant is a Kirkland, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Adamas Consulting is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At Fractyl, we are focused on improving the health of people with Type 2 diabetes. We`ve created an innovative clinical procedure based on new insights into the root cause of the disease. We are currently engaged in clinical trials designed to prove that our innovative procedure can dramatically improve glucose control and reduce the need for additional medications. Our mission is to set people free from the daily burdens of Type 2 diabetes management, empower physicians with a safe and reliable therapeutic treatment, and lower the tremendous human and financial costs of diabetic complications for patients, hospitals, and payers.